Prestige Consumer Healthcare
PBH
#4019
Rank
NZ$4.95 B
Marketcap
NZ$103.04
Share price
-1.92%
Change (1 day)
-31.30%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$6.53

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$6.63. In 2024 the company made an earnings per share (EPS) of NZ$7.48 an increase over its 2023 EPS that were of NZ-$2.80.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.53-12.69%
2024NZ$7.48-367.08%
2023NZ-$2.80-138.33%
2022NZ$7.3111.7%
2021NZ$6.5413.6%
2020NZ$5.76-651.67%
2019NZ-$1.04-148.78%
2018NZ$2.14-83.29%
2017NZ$12.81437.23%
2016NZ$2.38-34.13%
2015NZ$3.6252.94%
2014NZ$2.37-8.11%
2013NZ$2.58
2011NZ$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.38 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$12.02 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.53 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.37-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.53-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$10.70 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$2.45-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.56-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
NZ-$51.54-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.12-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel